Abstract

Cancer is a major public health problem in Indonesia, becoming the 7th largest cause of death based on a national survey in 2007, accounting for 5.7 of all mortality. A cancer registry was started in 1970, but it was partial and was stopped mainly because no government body was responsible. Realizing the above situation, the Indonesian government established the Sub Directorate of Cancer Control within the Ministry of Health, with responsibility for developing a national cancer control program, including a cancer registry. A sustainable cancer registry was then started in 2007 within Jakarta Province, first hospital-based but then expanded to be population-based. Steps of cancer registration in Jakarta are data collection, data verification, data validation, data management and analysis, and data publication. Data collection is conducted by health facilities (hospitals, laboratories, primary health centers) at the district/municipal level, with reports to the provincial level. Data are collected passively by holding meetings every three months in the district/municipality. Verification of data is the responsibility of the medical doctor or pathologist in each data source. Data validation is conducted by a team in the cancer registry, consisting of district/municipal/province health officers, pathologists, and registrars. Data management and analyses are conducted by a cancer registry team at the provincial level, assisted by the national team. We use software named Indonesian Cancer Registry System (SRIKANDI) which is adopted from CanReg4 IARC. Data from the population-based cancer registry in Jakarta Province showed the leading cancers among females in 2005-2007 to be breast cancer, cervical cancer, ovarian cancer, colorectal cancer and among males are bronchus and lung cancer, colorectal cancer, liver cancer, pharyngeal cancer, and prostate cancer. The leading childhood cancers are leukaemia and retinoblastoma.

Highlights

  • One main public health problem in Indonesia is cancer

  • We use software named Indonesian Cancer Registry System (SRIKANDI) which is adopted from CanReg4 International Agency for Research on Cancer (IARC)

  • Data resulted from Jakarta Cancer registry shows that top 10 leading cancers among felame 2005-2007 are breast cancer, cervical cancer (9.25 per 100,000), ovarium cancer (4.27 per 100,000), colorectal cancer (3.15 per 100,000), and bronchus and lung cancer (2.40 per 100,000), thyroid cancer (2.21 per 100,000), corpus utery cancer (1.76 per 100,000), pharingeal cancer (1.72 per 100,000), leukaemia (1.61 per 100,000), and liver cancer (1.41 per 100,000)

Read more

Summary

Introduction

One main public health problem in Indonesia is cancer. Based on Basic Health Research 2007, cancer is the 7th cause of death among all causes of deaths (5,7%). Population-based cancer registry is registry which is conducted based on cancer data in a certain population from all health facilities diagnosing and treating cancer, such as hospital, laboratory, health center, and clinic This registry is aimed to get cancer burden in a certain population, both morbidity (prevalence, incidence) and mortality, that will be sources of planning and evaluation of cancer control program. The registry was started by hospital based, expanded to be population-based This model is developed by sub directorate of cancer control in collaboration with many parties such as directorate of referral medical services, Dharmais National Cancer Hospital, Provincial Health Office of Jakarta. This model becomes reference on developing cancer regsitry in other areas in Indonesia

Procedures
Findings
Conclusions and Recommendations

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.